In conclusion, although studies on physiological functions and circulating levels of irisin have shown much controversy in humans, FNDC5/irisin has raised great expectations as a potential target in the conservative treatment of obesity. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.